Cargando…
Tongxinluo-pretreated mesenchymal stem cells facilitate cardiac repair via exosomal transfer of miR-146a-5p targeting IRAK1/NF-κB p65 pathway
BACKGROUND: Bone marrow cells (BMCs), especially mesenchymal stem cells (MSCs), have shown attractive application prospects in acute myocardial infarction (AMI). However, the weak efficacy becomes their main limitation in clinical translation. Based on the anti-inflammation and anti-apoptosis effect...
Autores principales: | Xiong, Yuyan, Tang, Ruijie, Xu, Junyan, Jiang, Wenyang, Gong, Zhaoting, Zhang, Lili, Ning, Yu, Huang, Peisen, Xu, Jun, Chen, Guihao, Li, Xiaosong, Hu, Mengjin, Xu, Jing, Wu, Chunxiao, Jin, Chen, Li, Xiangdong, Qian, Haiyan, Yang, Yuejin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9264662/ https://www.ncbi.nlm.nih.gov/pubmed/35799283 http://dx.doi.org/10.1186/s13287-022-02969-y |
Ejemplares similares
-
Sequential transplantation of exosomes and mesenchymal stem cells pretreated with a combination of hypoxia and Tongxinluo efficiently facilitates cardiac repair
por: Xiong, Yuyan, et al.
Publicado: (2022) -
Atorvastatin-pretreated mesenchymal stem cell-derived extracellular vesicles promote cardiac repair after myocardial infarction via shifting macrophage polarization by targeting microRNA-139-3p/Stat1 pathway
por: Ning, Yu, et al.
Publicado: (2023) -
Tongxinluo attenuates oxygen-glucose-serum deprivation/restoration-induced endothelial barrier breakdown via peroxisome proliferator activated receptor-α/angiopoietin-like 4 pathway in high glucose-incubated human cardiac microvascular endothelial cells
por: Qi, Kang, et al.
Publicado: (2020) -
Mendelian Randomization Study Does Not Support a Bidirectional Link between Atherosclerosis and Venous Thromboembolism
por: Hu, Mengjin, et al.
Publicado: (2023) -
China Tongxinluo Study for myocardial protection in patients with Acute Myocardial Infarction (CTS-AMI): Rationale and design of a randomized, double-blind, placebo-controlled, multicenter clinical trial
por: Xu, Yi, et al.
Publicado: (2020)